采纳股份 reported revenue of ¥0.27B for the period ended 2026-06-30, +72.2% year on year. Net income was ¥0.01B, a 3.0% net margin on a 24.2% gross margin. The largest revenue line is 医疗器械 at 67% of the total. Free cash flow for the period was ¥-0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.27B | +72.2% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.00B | — |
| Net income | ¥0.01B | -5.9% |
| Gross margin | 24.2% | Net margin 3.0% |
| Revenue Q/Q | -7.0% | — |
| Segment | Revenue | Share |
|---|---|---|
| 医疗器械 | ¥0.18B | 67.2% |
| 动物器械 | ¥0.07B | 25.0% |
| 实验室耗材 | ¥0.01B | 4.8% |
| 其他 | ¥0.01B | 3.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.21B | 75.8% |
| R&D | ¥0.02B | 6.4% |
| SG&A | ¥0.04B | 14.8% |
| Tax & other | ¥-0.00B | -1.4% |
| Item | Amount |
|---|---|
| Total assets | ¥2.26B |
| Total liabilities | ¥0.35B |
| Shareholders' equity | ¥1.90B |
| Equity / assets | 84.4% |
| Operating cash flow | ¥0.00B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥-0.01B |
| Cash conversion (OCF / net income) | 298% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
奕东电子 ・ 腾亚精工 ・ 达嘉维康 ・ 武汉天源 ・ 强瑞技术 ・ 瑞纳智能 ・ 西点药业 ・ 聚赛龙 ・ 满坤科技 ・ 金钟股份 ・ 瑞德智能 ・ 招标股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies